The largest database of trusted experimental protocols

4 protocols using chlorpromazine

1

Bacterial Invasion Assay of L. monocytogenes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Overnight culture of L. monocytogenes strains were deposited onto TG cells at a multiplicity of infection (MOI) of 10 by centrifugation at 150 × g for 10 min at room temperature. To measure the efficiency of bacterial uptake, the infected cells were incubated at 37°C for 30 min, washed once with TS medium, and then incubated in TS medium containing gentamicin (50 µg/ml) for 30 min. The cells were washed thrice with phosphate-buffered saline (PBS) and lysed with cold distilled water. Colony forming units (CFUs) were determined by serial dilution on BHI agar plates. Wortmannin (5 μM, Sigma), Akt 1/2 kinase inhibitor (20 μM, Sigma), nystatin (20 μg/ml, Wako, Osaka, Japan), β-cyclodextrin (5 μg/ml, Wako), chlorpromazine (15 μg/ml, Wako), or amiloride (indicated concentrations, Sigma) was added to the RPMI 1640 medium 1 h before infection. Recombinant IFN-γ (3,000 units/ml, Cedarlane Laboratories, Ontario, Canada) was added to the TS medium 24 h before infection.
+ Open protocol
+ Expand
2

Imaging CysC Endocytosis in N2a Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
N2a cells were seeded at 1.0 × 105 cells/ml in poly-D-lysine-coated 35 mm glass-bottomed dishes (MatTek Corp., Ashford, MA, USA). The medium was replaced with the differentiation medium containing 1 μM FITC-CysC or 300 nM rapamycin at 6 h after the transfection of pcDNA3.3-SOD1 or pAcGFP-N1-SOD1. The cells were further incubated for 24 h. To determine the CysC endocytotic pathway, the cells were treated with 25 μM chlorpromazine (Wako), 5 mg/ml filipin III (Enzo Life Sciences Inc., Farmingdale, NY, USA) or 25 μM 5-(N-Ethyl-N-isopropyl) amiloride (Enzo) for 1 h. The medium was replaced with the differentiation one with or without 1 μM FITC-CysC and incubated for another 1 h. The cells were stained with Lysotracker-Red (Life Technologies) according to the manufacturer's instructions to visualize the lysosomal acidic components. The cells were washed with PBS twice and observed by confocal laser scanning microscopy.
+ Open protocol
+ Expand
3

Toxicity Assessment of Commonly Used Drugs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following drugs were used for toxicity assessment in this study: amiodarone (TCI, Tokyo, Japan, A2530-1G), atorvastatin (TCI, A2476-1G), clotrimazole (Wako, Tokyo, Japan, 035-16021), aspirin (Wako, 015-10262), cyclosporin A (Wako, 031-24931), chlorpheniramine (Wako, 030-13271), chlorpromazine (Wako, 033-10581), and ibuprofen (Wako, 098-02641). All drugs were diluted with DMSO to the desired concentrations.
+ Open protocol
+ Expand
4

Pharmacological Compound Acquisition for Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Materials The following 47 compounds were purchased from Wako Pure Chemical Industries, Ltd., Osaka, Japan for use in this study: acetylsalicylic acid, acyclovir, allopurinol, amitriptyline, amoxicillin, azathioprine, azithromycin, budesonide, caffeine, carbamazepine, chloramphenicol, chlorpheniramine maleate salt, chlorpromazine, diethylcarbamazine, digoxin, diphenhydramine hydrochloride, doxycycline, erythromycin, ethosuximide, fluconazole, folic acid, furosemide, haloperidol, hydrochlorothiazide, hydrocortisone, ibuprofen, isoniazid, loratadine, metformin, metoclopramide, metronidazole, nitrofurantoin, ondansetron, oseltamivir, paracetamol, phenytoin, potassium iodide, prednisolone, primaquine, propranolol, propylthiouracil, quinine hydrochloride, salbutamol, spironolactone, sulfamethoxazole, valproic acid and vancomycin.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!